Aerie Pharmaceuticals reported $7.88M in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Aerie Pharmaceuticals AERI:US $ 7.88M 0.41M
Alimera Sciences ALIM:US $ 6.6M 2.1M
Amarin AMRN:US $ 90.75M 24.17M
Bluebird Bio BLUE:US $ 28.35M 2.47M
Cara Therapeutics CARA:US $ 5.59M 31K
Coherus Biosciences CHRS:US $ 21.09M 4.93M
Endo International Ordinary Shares ENDP:US $ 101.01M 22.12M
Horizon Pharma HZNP:US $ 67.01M 36.89M
Insmed INSM:US $ 48.57M 12.79M
JAZZ PHA JAZZ:US $ 73.34M 26.96M
Merk MRK:US $ 3715M 894M
Mirati Therapeutics MRTX:US $ 27.94M 7.22M
Novartis NOVN:VX 5.08B 470M
Pacira Pharmaceuticals PCRX:US $ 14.84M 4.3M
Regeneron Pharmaceuticals REGN:US $ 470.3M 93.7M
Revance Therapeutics RVNC:US $ 10.02M 583K
Supernus Pharmaceuticals SUPN:US $ 12.32M 2.99M
Teva Pharmaceutical Industries TEVA:US $ 1750M 64M
Valeant Pharmaceuticals VRX:CN $ 471M 64M
Zoetis ZTS:US $ 402M 34M